Ketogenic Diet for Patients with Brain Cancer

Despite all the advances in surgery, radiation, and chemotherapy malignant brain tumor survival rates have not changed in 20 years. Improvements in survival require the design of novel therapies that take advantage of physical traits common in tumor cells. A high fat, low carbohydrate and protein ketogenic diet (KD) causes the body to shift metabolically from glucose to ketones as the primary source of energy. The KD has been shown to improve survival in mouse models of malignant brain tumors, and research has shown that it potentiates the effects of radiation and chemotherapy in vitro and in vivo and appears to have additional anti-tumor effects even in the presence of normal glucose levels. This session will provide an overview of the KD, some of the recent advances of the diet and a case study analysis based a female patient with a malignant anaplastic astrocytoma who followed a KD during standard treatment of radiation and chemotherapy.


Leonora Renda RDN, Manager of Nutritional Services with Dignity Health at Chandler Regional and Mercy Gilbert Medical Centers in Phoenix, Arizona

Length: 44min

The opinions expressed in this presentation are that of the presenter and do not necessarily reflect those of Dietitians of Canada. Further, this presentation should not be reproduced in full or in part without the express written consent of the presenter.  

Les opinions exprimées dans cette présentation sont celles du présentateur ou de la présentatrice et ne reflètent pas nécessairement celles des Diététistes du Canada. Par ailleurs, cette présentation ne devrait pas être reproduite, que ce soit en partie ou dans son intégralité, sans le consentement écrit exprès du présentateur ou de la présentatrice.

Last Updated: January 12, 2018


# Name Type
1 AB NSD 2017 Speaker 3 Leonora Renda 1.1 MP3 Mono 128 CBR
3 Professional Development Record
4 Registre de developpement professionnel